Icahn School of Medicine at Mount Sinai
Dr. Ross Cagan attended the University of California, Los Angeles, and received his Ph.D. from Princeton University. He leads the Cagan Laboratory at the Ichahn School of Medicine at Mount Sinai, a research laboratory targeted primarily at cancer and diabetes, including diabetic nephropathy. His team focuses on a genetic and drug screening approach, utilizing the fruit fly genus Drosophila in their research. The short life span of the fly offers them the ability to evolve many generations in a relatively short time period. Dr. Cagan’s integrated approach brings genes and drugs identified in Drosophila research to other animal models, and ultimately to human studies.
Na J, Cagan R. The Drosophila nephrocyte: Back on stage. J Am Soc Nephrol. 2013; 24(2), 161-163.
Johnson RI, Bao S, Cagan RL. Interactions between Drosophila IgCAM adhesion receptors and cindr, the Cd2ap/Cin85 ortholog. Dev Dyn. 2012; 241(12), 1933-1943.
Cagan RL. The Drosophila nephrocyte. Curr Opin Nephrol Hypertens. 2011; 20(4), 409-415.
Rusconi JC, Fink JL, Cagan R. Klumpfuss regulates cell death in the Drosophila retina. Mech Dev. 2004; 121(6), 537-546.
Cagan R. The signals that drive kidney development: a view from the fly eye. Curr Opin Nephrol Hypertens. 2003; 12(1), 11-17.